Interstitial lung diseases in a resource-limited setting: the case of India

Z.F. Udwadia, T. Sen, S.K. Jindal

Source: Eur Respir Mon; 2009: 46: 357–374
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z.F. Udwadia, T. Sen, S.K. Jindal. Interstitial lung diseases in a resource-limited setting: the case of India. Eur Respir Mon; 2009: 46: 357–374

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung diseases in Europe
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011

Management of severe COVID-19 in resource-poor settings
Source: Virtual Congress 2020 – Hot topics in intensive care: COVID-19: Lessons learned
Year: 2020


Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Interstitial lung diseases frequency in a regional reference center in Brazil
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Interstitial lung diseases today
Source: Eur Respir Mon; 2009: 46: 1–3
Year: 2009

Recognition of interstitial lung disease in India
Source: Eur Respir J 2007; 30: Suppl. 51, 764s
Year: 2007

A review of the management of MDR-TB in a resource-limited setting in India
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010


Types of interstitial lung diseases and comparison on survival of idiopathic and secondary types in a tertiary care setting of Sri Lanka
Source: International Congress 2014 – ILDs 6
Year: 2014

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
Source: ERJ Open Res, 8 (1) 00597-2021; 10.1183/23120541.00597-2021
Year: 2022



Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

A qualitative study on the development of pulmonary rehabilitation for patients with chronic lung disease in Kampala, Uganda
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Interstitial lung disease: specific issues in the Far East
Source: Eur Respir Mon; 2009: 46: 375–385
Year: 2009

Pulmonary rehabilitation in low-resource settings
Source: Eur Respir Monogr 2021; 93: 273-293
Year: 2021


Interstitial lung diseases: a clinical update
Source: Eur Respir J 2001; 18: 1S
Year: 2001


Smoking and obstructive lung function disorders in three rural districts in Northwest Russia
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013


Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


A development study of pulmonary rehabilitation for patients with chronic lung disease in Uganda
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020

Rheumatoid arthritis associated interstitial lung disease in KwaZulu-Natal, South Africa: Clinical profile and treatment outcomes
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020